Taysha Gene Therapies, Inc. business relationships
Companies named in Taysha Gene Therapies, Inc.’s 10-K filed 2026-03-19, and public companies whose annual reports name Taysha Gene Therapies, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 5 / 100 Top 3% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in Taysha Gene Therapies, Inc.’s annual report 1
“License Agreement, by and between the Company and Abeona Therapeutics Inc., dated as of October 29, 2020 (incorporated by reference to Exhibit 10.5 to the Company's Annual Report on Form 10-K (File No. 001-39536), filed with the Securities and Exchange Commission on March 2, 2021.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.